Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with type 2 diabetes
- People aged between 18 and 80 years old (inclusive)
Who may not be able to join:
- People who are unable or unwilling to give their consent to take part in the study
- People who have previously received injections into the eye to treat diabetic macular oedema (a diabetes-related eye condition)
- People who have a known infectious disease that could put the study team at risk, such as tuberculosis (TB), HIV, or hepatitis
- People who are 17 years old or younger, or 81 years old or older
- People who have a known inherited (genetic) condition that affects how the body processes fats (lipids)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francis WB Sanders, MB BChir PhD FRCOphth, Hywel Dda University Health Board
Phone: +447717171199
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Analysis of serum lipidome of people with differing severity of DR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.